Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients

Albertus M Scheule1, Grenith J Zimmerman, Joyce K Johnston

  • 1Department of Surgery, Loma Linda University School of Medicine, and Children's Hospital, Loma Linda, Calif, USA.

Circulation
|October 2, 2002
PubMed

Insights

Utilizing donor hearts with prolonged graft ischemia (>8 hours) did not adversely affect late outcomes in pediatric heart transplant recipients. This approach may help expand the donor pool for life-saving procedures.

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Pediatric Medicine

Background:

  • Expanding the donor heart pool is crucial for pediatric heart transplantation.
  • Prolonged graft ischemia is a limiting factor in organ utilization.

Purpose of the Study:

  • To evaluate the impact of prolonged ischemic times on outcomes in pediatric heart transplant recipients.
  • To determine if donor hearts preserved with extended cold ischemia impact long-term graft survival and post-transplant complications.

Main Methods:

  • Retrospective review of 363 pediatric heart transplant recipients (aged 1 day to 17 years).
  • Comparison of outcomes between recipients of hearts with prolonged ischemic times (>8 hours) and short ischemic times (<=90 minutes).
  • Analysis of graft survival, rejection episodes, hospital readmissions, and development of post-transplant coronary artery disease.

Main Results:

  • No significant differences in actuarial graft survival between prolonged ischemic time (PIT) and short ischemic time (SIT) groups.
  • Similar rates of rejection episodes and hospital readmissions in the first post-transplantation year for both groups.
  • Cardiopulmonary bypass time was significantly longer in the PIT group.

Conclusions:

  • Donor hearts preserved with single-dose cold crystalloid cardioplegia and prolonged cold ischemia (>8 hours) do not adversely affect late outcomes in pediatric heart transplant recipients.
  • This finding supports the potential to expand the donor pool by utilizing organs with extended preservation times.
  • Late outcomes, including graft survival and complication rates, were comparable between groups.
Abstract